-
1دورية أكاديمية
المؤلفون: Wienke, J, Visser, LL, Kholosy, WM, Keller, KM, Barisa, M, Poon, E, Munnings-Tomes, S, Himsworth, C, Calton, E, Rodriguez, A, Bernardi, R, Ham, FV, Hooff, SRV, Matser, YAH, Tas, ML, Langenberg, KPS, Lijnzaad, P, Borst, AL, Zappa, E, Bergsma, FJ, Strijker, JGM, Verhoeven, BM, Mei, SL, Kramdi, A, Restuadi, R, Sanchez-Bernabeu, A, Cornel, AM, Holstege, FCP, Gray, JC, Tytgat, GAM, Scheijde-Vermeulen, MA, Wijnen, MHWA, Dierselhuis, MP, Straathof, K, Behjati, S, Wu, W, Heck, AJR, Koster, J, Nierkens, S, Janoueix-Lerosey, I, Krijger, RRD, Baryawno, N, Chesler, L, Anderson, J, Caron, HN, Margaritis, T, Noesel, MMV, Molenaar, JJ
المصدر: Cancer cell. 42(2):283
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2دورية أكاديمية
المؤلفون: Strijker JGM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Pscheid R; Gadeta B.V., 3584 CM Utrecht, The Netherlands., Drent E; Gadeta B.V., 3584 CM Utrecht, The Netherlands., van der Hoek JJF; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Koopmans B; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Ober K; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van Hooff SR; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Kholosy WM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Coomans C; Gadeta B.V., 3584 CM Utrecht, The Netherlands., Bisso A; Gadeta B.V., 3584 CM Utrecht, The Netherlands., van Loenen MM; Gadeta B.V., 3584 CM Utrecht, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Wienke J; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
المصدر: Journal of personalized medicine [J Pers Med] 2021 Sep 17; Vol. 11 (9). Date of Electronic Publication: 2021 Sep 17.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE
-
3دورية أكاديمية
المؤلفون: Kholosy WM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Visscher M; NTrans Technologies BV, Heidelberglaan 7, 3584 CS Utrecht, the Netherlands., Ogink K; NTrans Technologies BV, Heidelberglaan 7, 3584 CS Utrecht, the Netherlands., Buttstedt H; NTrans Technologies BV, Heidelberglaan 7, 3584 CS Utrecht, the Netherlands., Griffin K; NTrans Technologies BV, Heidelberglaan 7, 3584 CS Utrecht, the Netherlands., Beier A; KNAW-Hubrecht Institute, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Gerlach JP; NTrans Technologies BV, Heidelberglaan 7, 3584 CS Utrecht, the Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Geijsen N; KNAW-Hubrecht Institute, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., de Boer M; NTrans Technologies BV, Heidelberglaan 7, 3584 CS Utrecht, the Netherlands., Chatsisvili A; NTrans Technologies BV, Heidelberglaan 7, 3584 CS Utrecht, the Netherlands. Electronic address: a.chatsisvili@uu.nl.
المصدر: Journal of biotechnology [J Biotechnol] 2021 Sep 10; Vol. 338, pp. 71-80. Date of Electronic Publication: 2021 Jul 13.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8411927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4863 (Electronic) Linking ISSN: 01681656 NLM ISO Abbreviation: J Biotechnol Subsets: MEDLINE
مواضيع طبية MeSH: CRISPR-Cas Systems*/genetics , T-Lymphocytes*, Gene Editing ; Genome, Human ; HEK293 Cells ; Humans
-
4دورية أكاديمية
المؤلفون: Martinez Sanz P; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands p.martinezsanz@sanquin.nl., van Rees DJ; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., van Zogchel LMJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands., Klein B; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Bouti P; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Olsman H; Laboratory for Immunotherapy, Sanquin Research, Amsterdam, The Netherlands., Schornagel K; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Kok I; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Sunak A; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Leeuwenburg K; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Timmerman I; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kholosy WM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Bruggen R; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., van den Berg TK; Laboratory for Immunotherapy, Sanquin Research, Amsterdam, The Netherlands.; Department of Molecular Cell Biology and Immunology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Kuijpers TW; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands.; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital UMC, Amsterdam, The Netherlands., Matlung HL; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Franke K; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands.
المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 May; Vol. 9 (5).
نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Adjuvants, Immunologic/*pharmacology , Antibodies, Monoclonal/*pharmacology , Antineoplastic Agents, Immunological/*pharmacology , Antineoplastic Combined Chemotherapy Protocols/*pharmacology , Cytotoxicity, Immunologic/*drug effects , Granulocyte Colony-Stimulating Factor/*pharmacology , Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology , Neuroblastoma/*drug therapy , Neutrophils/*drug effects, CD11b Antigen/metabolism ; CD18 Antigens/metabolism ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Coculture Techniques ; Humans ; Neuroblastoma/immunology ; Neuroblastoma/metabolism ; Neuroblastoma/pathology ; Neutrophils/immunology ; Neutrophils/metabolism ; Neutrophils/pathology ; Receptors, IgG/metabolism ; Trogocytosis/drug effects ; Tumor Microenvironment
-
5دورية أكاديمية
المؤلفون: Kildisiute G; Wellcome Sanger Institute, CB10 1SA Hinxton, UK., Kholosy WM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., Young MD; Wellcome Sanger Institute, CB10 1SA Hinxton, UK. my4@sanger.ac.uk k.straathof@ucl.ac.uk j.j.molenaar@prinsesmaximacentrum.nl sb31@sanger.ac.uk., Roberts K; Wellcome Sanger Institute, CB10 1SA Hinxton, UK., Elmentaite R; Wellcome Sanger Institute, CB10 1SA Hinxton, UK., van Hooff SR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., Pacyna CN; Wellcome Sanger Institute, CB10 1SA Hinxton, UK., Khabirova E; Wellcome Sanger Institute, CB10 1SA Hinxton, UK., Piapi A; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK., Thevanesan C; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK., Bugallo-Blanco E; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK., Burke C; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK., Mamanova L; Wellcome Sanger Institute, CB10 1SA Hinxton, UK., Keller KM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., Langenberg-Ververgaert KPS; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., Lijnzaad P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., Tas ML; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands., Del Valle I; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK., Barone G; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK., van der Linden R; Hubrecht Institute, KNAW, 3584 CT Utrecht, Netherlands., Duncan C; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK., Anderson J; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK., Achermann JC; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK., Haniffa M; Wellcome Sanger Institute, CB10 1SA Hinxton, UK.; Institute of Cellular Medicine, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals, NHS Foundation Trust, NE2 4LP Newcastle upon Tyne, UK., Teichmann SA; Wellcome Sanger Institute, CB10 1SA Hinxton, UK., Rampling D; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK., Sebire NJ; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK., He X; MRC-WT Cambridge Stem Cell Institute, University of Cambridge, CB2 0QQ Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, CB2 0QQ Cambridge, UK., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands.; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, Netherlands., Barker RA; MRC-WT Cambridge Stem Cell Institute, University of Cambridge, CB2 0QQ Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, CB2 0QQ Cambridge, UK., Meyer KB; Wellcome Sanger Institute, CB10 1SA Hinxton, UK., Bayraktar O; Wellcome Sanger Institute, CB10 1SA Hinxton, UK., Straathof K; UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK. my4@sanger.ac.uk k.straathof@ucl.ac.uk j.j.molenaar@prinsesmaximacentrum.nl sb31@sanger.ac.uk.; Great Ormond Street Hospital for Children (GOSH), NHS Foundation Trust, NIHR Great Ormond Street Hospital Biomedical Research Centre, WC1N 3JH London, UK., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, Netherlands. my4@sanger.ac.uk k.straathof@ucl.ac.uk j.j.molenaar@prinsesmaximacentrum.nl sb31@sanger.ac.uk., Behjati S; Wellcome Sanger Institute, CB10 1SA Hinxton, UK. my4@sanger.ac.uk k.straathof@ucl.ac.uk j.j.molenaar@prinsesmaximacentrum.nl sb31@sanger.ac.uk.; Cambridge University Hospitals NHS Foundation Trust, CB2 0QQ Cambridge, UK.; Department of Paediatrics, University of Cambridge, CB2 0QQ Cambridge, UK.
المصدر: Science advances [Sci Adv] 2021 Feb 05; Vol. 7 (6). Date of Electronic Publication: 2021 Feb 05 (Print Publication: 2021).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
مواضيع طبية MeSH: Neural Stem Cells*/metabolism , Neuroblastoma*/genetics , Neuroblastoma*/metabolism , Neuroblastoma*/pathology, Child ; Humans ; Neural Crest/metabolism ; RNA, Messenger/genetics ; Transcriptome
-
6دورية أكاديمية
المؤلفون: Wellens LM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands.; Cancer Genomics Center, Utrecht, The Netherlands., Deken MM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Sier CFM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Johnson HR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands.; Cancer Genomics Center, Utrecht, The Netherlands., de la Jara Ortiz F; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Bhairosingh SS; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Houvast RD; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Kholosy WM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Baart VM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Pieters AMMJ; Department of Surgery, Maasstad Hospital, Rotterdam, The Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands.; Cancer Genomics Center, Utrecht, The Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands.; Cancer Genomics Center, Utrecht, The Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Vahrmeijer AL; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Hubrecht Institute - KNAW, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Cancer Genomics Center, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.
المصدر: Scientific reports [Sci Rep] 2020 Oct 19; Vol. 10 (1), pp. 17667. Date of Electronic Publication: 2020 Oct 19.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
مواضيع طبية MeSH: Benzenesulfonates/*therapeutic use , Brain Neoplasms/*surgery , Fluorescent Dyes/*therapeutic use , Gangliosides/*metabolism , Indoles/*therapeutic use , Neuroblastoma/*surgery, Animals ; Brain Neoplasms/metabolism ; Cell Line, Tumor ; Female ; Flow Cytometry ; Humans ; Mice ; Mice, Nude ; Neoplasm Transplantation ; Neoplasms, Experimental ; Neuroblastoma/metabolism ; Tissue Array Analysis
-
7دورية أكاديمية
المؤلفون: Decaesteker B; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium. bieke.decaesteker@ugent.be.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium. bieke.decaesteker@ugent.be., Denecker G; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Van Neste C; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Dolman EM; Princess Máxima Center for Pediatric Oncology, Department of Translational Research, Utrecht, 3584, The Netherlands., Van Loocke W; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Gartlgruber M; Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany., Nunes C; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., De Vloed F; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Depuydt P; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Verboom K; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Rombaut D; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Loontiens S; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., De Wyn J; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Kholosy WM; Princess Máxima Center for Pediatric Oncology, Department of Translational Research, Utrecht, 3584, The Netherlands., Koopmans B; Princess Máxima Center for Pediatric Oncology, Department of Translational Research, Utrecht, 3584, The Netherlands., Essing AHW; Princess Máxima Center for Pediatric Oncology, Department of Translational Research, Utrecht, 3584, The Netherlands., Herrmann C; Institute of Pharmacy and Molecular Biotechnology, and Bioquant Center, University of Heidelberg, Im Neuenheimer Feld 267, Heidelberg, 69120, Germany.; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120, Germany., Dreidax D; Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany., Durinck K; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Deforce D; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.; Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, 9000, Belgium., Van Nieuwerburgh F; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.; Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, 9000, Belgium., Henssen A; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, 13353, Germany.; German Cancer Consortium (DKTK), Heidelberg, 69120, Germany.; Berlin Institute of Health, Berlin, 13353, Germany., Versteeg R; Department of Oncogenomics, Academic Medical Center, Amsterdam, 1105, AZ, Netherlands., Boeva V; Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris Descartes University UMR-S1016, Paris, 75014, France., Schleiermacher G; Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Laboratory Recherche Translationnelle en Oncologie Pédiatrique (RTOP), Laboratoire 'Gilles Thomas', Institut Curie, Department of Translational Research, Institut Curie, SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, 75248, France., van Nes J; Department of Oncogenomics, Academic Medical Center, Amsterdam, 1105, AZ, Netherlands., Mestdagh P; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Vanhauwaert S; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Schulte JH; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, 13353, Germany., Westermann F; Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Department of Translational Research, Utrecht, 3584, The Netherlands., De Preter K; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium., Speleman F; Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium. Franki.speleman@ugent.be.; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium. Franki.speleman@ugent.be.
المصدر: Nature communications [Nat Commun] 2018 Nov 19; Vol. 9 (1), pp. 4866. Date of Electronic Publication: 2018 Nov 19.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
مواضيع طبية MeSH: Gene Expression Regulation, Neoplastic*, Brain Neoplasms/*genetics , Forkhead Box Protein M1/*genetics , Kv Channel-Interacting Proteins/*genetics , N-Myc Proto-Oncogene Protein/*genetics , Neuroblastoma/*genetics , Repressor Proteins/*genetics , T-Box Domain Proteins/*genetics, Antineoplastic Agents/pharmacology ; Azepines/pharmacology ; Brain Neoplasms/drug therapy ; Brain Neoplasms/metabolism ; Brain Neoplasms/pathology ; Cell Line, Tumor ; Cell Survival/drug effects ; Cyclin-Dependent Kinases/genetics ; Cyclin-Dependent Kinases/metabolism ; DNA Copy Number Variations ; Epigenesis, Genetic ; Forkhead Box Protein M1/metabolism ; HEK293 Cells ; Histones/genetics ; Histones/metabolism ; Humans ; Kv Channel-Interacting Proteins/metabolism ; N-Myc Proto-Oncogene Protein/metabolism ; Neuroblastoma/drug therapy ; Neuroblastoma/metabolism ; Neuroblastoma/pathology ; Organoids/drug effects ; Organoids/metabolism ; Organoids/pathology ; Panobinostat/pharmacology ; Phenylenediamines/pharmacology ; Pyrimidines/pharmacology ; Repressor Proteins/metabolism ; Signal Transduction ; T-Box Domain Proteins/metabolism ; Triazoles/pharmacology ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Cyclin-Dependent Kinase-Activating Kinase